HOTEL INFO: please call us to assist with your reservation

The Broadmoor Resort— Classic rooms $339 per night, Superior rooms $369 per night, and Premier rooms $399 per night, single or double occupancy.

www.thebroadmoor.com

Dr. Reginal D. Harris, JD, PharmD, RPh, CPh, cMTM

InfoSource Communications, LLC

Dr. Reginal Harris founded InfoSource Communications in 1999 to offer pharmacy consulting, staffing, and Joint Commission readiness for institutional, governmental, and managed care pharmacies. His exemplary practice as a Registered Pharmacist in Texas, Illinois, and Florida spanned over 22 years. In November 2019, the company recognized and now provides legal consultation, representation, and services to individuals, non-profit, for-profit, and governmental clients tailored to meet their administrative, legal, corporate, and leadership needs. Dr Harris is a Texas licensed attorney admitted to practice before all Texas courts, the Department of Veterans Affairs, Board of Veterans Appeals, U.S. Court of Appeals for Veterans Claims, U.S. District Court for the Southern District of Texas and the Western District of Texas. For more than 30 years, he has educated and mentored thousands of students while serving as clinical or adjunct faculty for Florida A&M University, Northwest Vista College, Nova Southeastern University, San Antonio College, Texas A&M University (Kingsville), Texas Southern University, University of Colorado (Aurora), University of Florida, and the University of the Incarnate World. He has authored five books, eight e-books, seven CD-ROM training programs, six legal articles, and an Amicus brief that was accepted by the U.S. Supreme Court (2017).

Friday, April 24, 2026

(MTM) PHARMACISTS PROVIDING A VARIETY OF MEDICATION THERAPY MANAGEMENT SERVICES FOR COMPENSATION

ACPE# TBA

Objectives:

1.  Discuss legislative intent of providing Medication Therapy Management Services (MTMS) to targeted beneficiaries using Prescription Drug Plans.
2.  Apply the five MTM Core Elements to conduct medication therapy review, identify medication related problems, create a medication action plan, and provide patient medication list.
3.  Describe and demonstrate documentation, interventions, referrals, follow-ups using the CMS and SOAP formats.
4.  Discuss the benefits of using SWOT analysis to determine a pharmacy’s strengthsand weaknesses on integrating and offering MTM services in various pharmacy settings.
5.  Evaluate evidence-based strategies for pharmacists being compensated for providing MTM and other patient care services.
6.  Discuss elements of an effective marketing plan that attracts patients, providers, employers, and payers to your pharmacy for MTM and other patient care service———————————————————————————————————————————————————————————————–
   

   Saturday April 25, 2026

   PHARMACISTS ACCOUNTABILITY: PREVENTING REGULATORY VIOLATIONS WHEN RECEIVING, EVALUATING, DISPENSING, AND COUNSELING ON CONTROLLED SUBSTANCE PRESCRIPTIONS

   ACPE# TBA

   Objectives:

   1.  Define common terms relating to pathology of opioid misuse and addiction and what steps pharmacists can take when dispensing and counseling at-risk patients taking a controlled substance.
   2.  Describe how a state’s Prescription Drug Monitoring Program assists pharmacists when determining the validity, use, misuse, and abuse of controlled substances.
   3.  Describe how recent changes in the Controlled Substances Act help pharmacists identify “red flags” when receiving and evaluating controlled substance prescriptions.
   4.  Define the concept of Risk Evaluation & Mitigation Strategy (REMS) as an evidence-based approach of assessing patients with chronic pain who are initiated on opioid or other pain medications and how to calculate the morphine milligram equivalents.
   5. Utilize standardized scales and tools to document pain characteristics and to guide medication management decisions by comparing/contrasting “strengths v. weaknesses” and “specificity v. sensitivity” of the scales and tools.
   6.  Utilize the FDA education blueprint as a tool to identify patients showing signs of addiction, abuse, misuse, or overuse of pain medications.
   7. Apply the REMS and/or FDA approach to develop a comprehensive, customized treatment plan for a patient initiated on an opioid analgesic or other pain medications.
   8. Document treatment recommendations using the S.O.A.P. format to reinforce patient-clinician responsibilities.————————————————————————————————————————————————————————————————————————–Sunday April 26, 2026
      

      PHARMACY LAW & MEDICATION ERRORS 2026

      ACPE# TBA

      Objectives:
      1.  Discuss the legal aspects of incorporating Continuous Quality Improvements (CQI) into pharmacy practice operations using the “Root Cause Analysis” model to determine how a medication error occurred.
      2.  Discuss the legal aspects of incorporating CQI into pharmacy practice operations using the “Focus-PDSA” model to reduce the likelihood of medication errors occurring in the future.
      3.  Explain the legal benefits of using the Institute of Safe Medication Practices National Medication Reporting Program (ISMP MERP) and demonstrate how to use these free tools and resources to develop strategies that prevent medication errors.
      4.  Use case studies to apply legal aspects of CQI principles to determine the origination of various medication errors using the Root Cause Analysis model.
      5.  Use case studies to apply legal aspects of CQI principles that reduce the likelihood of medication errors occurring in the future by using the Focus-PDSA model.